https://clinicaltrials.gov/ct2/show/NCT03285711?type=Intr&cond=Lupus&phase=012345&lupd_s=01%2F25%2F2019&lupd_d=14
Condition : Lupus Membranous Nephropathy
Interventions : Drug: Filgotinib; Drug: GS-9876; Drug: Filgotinib placebo; Drug: GS-9876 placebo
Sponsor : Gilead Sciences
Active, not recruiting
Safety and Efficacy of Filgotinib and GS-9876 in Adults With Lupus Membranous Nephropathy (LMN)
NCT03285711
Mon, 18 Sep 2017 12:00:00 EDT
>>> updated February 8, 2019
